Wolfe Research initiated coverage of Merck (MRK) with a Peer Perform rating. The firm said the main sentiment driver for Merck is ...
Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...
Merck & Co. has struck a licensing deal with LaNova Medicines that is potentially worth more than $3 billion to the clinical-stage biotechnology company. Merck on Thursday said it has secured an ...
Merck & Co Inc. (MRK) and LaNova Medicines Ltd., a privately held clinical-stage biotechnology company Thursday said Merck has ...
The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 ...
Marktanalyse für Reagenzien-HEPPS-Puffer, Forschungsstudie mit Merck, Hopax Fine Chemicals, BioWORLD
Der Forschungsbericht des globalen HEPPS-Puffer in Reagenzienqualität-Marktes untersucht die aktuelle und zukünftige ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback